Effects of Minocycline Plus Tissue Plasminogen Activator Combination Therapy After Focal Embolic Stroke in Type 1 Diabetic Rats-Reference-Cited by-同舟云学术

Effects of Minocycline Plus Tissue Plasminogen Activator Combination Therapy After Focal Embolic Stroke in Type 1 Diabetic Rats

Published:2013-03 Issue:3 Volume:44 Page:745-752
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Fan Xiang¹,Lo Eng H.¹,Wang Xiaoying¹

Affiliation:

1. From the Departments of Neurology and Radiology, Neuroprotection Research Laboratory, Massachusetts General Hospital, Neuroscience Program, Harvard Medical School, Boston, MA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference38 articles.

1. Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke

2. Targeting Extracellular Matrix Proteolysis for Hemorrhagic Complications of tPA Stroke Therapy

3. Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis

4. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production

5. Baseline Diabetic Status and Admission Blood Glucose Were Poor Prognostic Factors in the EPITHET Trial

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes and Stroke—A Focused Review;Journal of Diabetology;2024-07

2. Naoxueshu oral liquid promotes hematoma absorption by targeting CD36 in M2 microglia via TLR4/MyD88/NF-κB signaling pathway in rats with intracerebral hemorrhage;Journal of Ethnopharmacology;2024-01

3. Neurovascular Inflammation and Complications of Thrombolysis Therapy in Stroke;Stroke;2023-10

4. Plasma derived extracellular vesicle biomarkers of microglia activation in an experimental stroke model;Journal of Neuroinflammation;2023-01-31

5. Risk Factors, Pathophysiologic Mechanisms, and Potential Treatment Strategies of Futile Recanalization after Endovascular Therapy in Acute Ischemic Stroke;Aging and disease;2023